RDNTRadNet, Inc.
61.67USD+4.03%Mkt Cap: 4.85B $P/E:

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its servic…

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/B
Avg
1M Perf
Lower
TMO
Thermo Fisher Scientific Inc.
$186.32BUSDP/E 27.6
DHR
Danaher Corporation
$134.82BUSDP/E 36.8
LONN
Lonza Group AG
$43.51BUSDP/E 42.0
IDXX
IDEXX Laboratories, Inc.
$41.53BUSDP/E 38.7
NTRA
Natera, Inc.
$38.88BUSD
A
Agilent Technologies, Inc.
$37.53BUSDP/E 26.7
WAT
Waters Corporation
$36.82BUSDP/E 47.7
IQV
IQVIA Holdings Inc.
$32.25BUSDP/E 24.0
ILMN
Illumina, Inc.
$26.60BUSDP/E 31.9
MTD
Mettler-Toledo International Inc.
$25.82BUSDP/E 30.0
DGX
Quest Diagnostics Incorporated
$23.46BUSDP/E 23.4
LH
Labcorp Holdings Inc.
$22.96BUSDP/E 24.8
GH
Guardant Health, Inc.
$19.89BUSD
MEDP
Medpace Holdings, Inc.
$15.12BUSDP/E 33.3
ERF
Eurofins Scientific SE
$12.91BUSDP/E 26.9
RVTY
Revvity, Inc.
$12.41BUSDP/E 53.5
CRL
Charles River Laboratories International, Inc.
$10.92BUSD
BIM
bioMérieux S.A.
$8.81BUSDP/E 20.6
TWST
Twist Bioscience Corporation
$6.41BUSD
BLLN
BillionToOne, Inc.
$5.52BUSDP/E 222.2
SHC
Sotera Health Company
$5.06BUSDP/E 43.3
VCYT
Veracyte, Inc.
$4.69BUSDP/E 54.4
DIA
DiaSorin S.p.A.
$3.65BUSDP/E 25.7
ADPT
Adaptive Biotechnologies Corporation
$3.43BUSD
GRAL
GRAIL, Inc.
$2.93BUSD
WGS
GeneDx Holdings Corp.
$2.04BUSD
NEO
NeoGenomics, Inc.
$1.90BUSD
VIMIAN
Vimian Group AB (publ)
$1.48BUSDP/E 37.4
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
CDNA
CareDx, Inc.
$1.47BUSD
PSNL
Personalis, Inc.
$1.40BUSD
OPK
OPKO Health, Inc.
$1.13BUSD
CBAV
Clínica Baviera, S.A.
$1.01BUSDP/E 21.1
CSTL
Castle Biosciences, Inc.
$723.37MUSD
LBIRD
Lumibird SA
$615.20MUSDP/E 40.1
FLGT
Fulgent Genetics, Inc.
$582.78MUSD
MYGN
Myriad Genetics, Inc.
$539.30MUSD
VOX
Voxel S.A.
$297.38MUSDP/E 3.0
EDT
Spectral Medical Inc.
$282.06MUSD
BDSX
Biodesix, Inc.
$233.52MUSD
IMDX
Insight Molecular Diagnostics Inc.
$190.51MUSD
SLV
Selvita S.A.
$147.80MUSD
XGN
Exagen Inc.
$112.34MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.2
BIOPOR
BioPorto A/S
$77.88MUSD
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$44.26MUSD
ABDX
Abingdon Health Plc
$27.97MUSD
NN6
NanoRepro AG
$27.15MUSD
GDR
genedrive plc
$22.69MUSD
SENZA
SenzaGen AB
$17.60MUSD
IMMNOV
Immunovia AB (publ)
$12.55MUSD
BMX
BioMaxima S.A.
$10.07MUSDP/E 63.2
ALPRE
Predilife S.A.
$9.85MUSD
VRCI
Verici Dx plc
$9.02MUSD
XWEL
XWELL, Inc.
$8.78MUSD
NDRA
ENDRA Life Sciences Inc.
$6.77MUSD
PRM
Proteome Sciences plc
$6.29MUSD
AVCR
Avricore Health Inc.
$5.98MUSD
BIAF
bioAffinity Technologies, Inc.
$5.10MUSD
OBD
Oxford BioDynamics Plc
$4.66MUSD
ISPC
iSpecimen Inc.
$3.81MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
TELO
Telo Genomics Corp.
$2.93MUSD
NOTV
Inotiv Inc
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.43MUSD
PRPH
ProPhase Labs, Inc.
$1.29MUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$14.0KUSD
Indicators:|

Key Statistics

Company
Market Cap4.85B $
Enterprise Value6.60B $
Revenue (TTM)2.14B $
Gross Profit235.49M $
Net Income (TTM)-18.65M $
Revenue/Share28.27 USD
Last Price61.67 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)
P/E (Forward)65.37
PEG0.96
EV/EBITDA26.10
EV/Revenue3.08
P/S2.26
P/B4.38
EPS (TTM)-0.17
EPS (Forward)0.94
52W Range
50.7631% of range85.84
52W High85.84 USD
52W Low50.76 USD
Profitability
Gross Margin11.54%
Oper. Margin-2.85%
EBITDA Margin11.79%
Profit Margin-0.91%
ROE-1.71%
ROA-0.50%
Growth
Revenue Growth22.10%
Earnings Growth
Cash Flow & Leverage
Operating CF298.82M $
CapEx (TTM)213.25M $
FCF Margin8.88%
FCF Yield3.93%
Net Debt1.48B $
Net Debt/EBITDA5.85
Balance Sheet
Debt/Equity1.71
Current Ratio1.17
Quick Ratio1.05
Book Value/Sh14.08 USD
Cash/Share5.791 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:2
Split DateNov 28, 2006
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)89.75 USD
Upside (mean)+45.5%
Target Range65.00 USD100.00 USD
$65.00+45.5% to mean$100.00
# Analysts8
Ownership
Shares Out.78.63M
Float66.24M
Insiders9.96%
Institutions100.11%
Short Interest
Short Ratio13.6d
Short % Float13.27%
Short % Out.11.22%
Shares Short8.82M
Short (prev mo.)9.05M
Technical
SMA 5056.08 (+10.0%)
SMA 20067.93 (-9.2%)
Beta1.39
S&P 52W Chg20.05%
Avg Vol (30d)769.64K
Avg Vol (10d)1.28M
Technical Indicators
RSI (14)63.4
MACD1.2071
MACD Signal0.5308
MACD Hist.+0.6762
BB Upper61.96 USD
BB Middle56.44 USD
BB Lower50.92 USD
BB Width19.56%
ATR (14)2.815 USD
Vol Ratio (20d)0.82x